FDA
approval
· 2022-08-29
FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
The FDA approved Lupin Pharmaceuticals' supplemental application for Losartan Potassium, authorizing changes to an already approved generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)